These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8458597)

  • 1. Pharmacokinetics and pharmacodynamics of zolpidem following repeated doses in hemodialyzed uraemic patients.
    Fillastre JP; Geffroy-Josse S; Etienne I; Dhib M; Rosenzweig P; Danjou P; Dubruc C; Bianchetti G
    Fundam Clin Pharmacol; 1993; 7(1):1-9. PubMed ID: 8458597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of co-administration of zolpidem with fluoxetine: pharmacokinetics and pharmacodynamics.
    Piergies AA; Sweet J; Johnson M; Roth-Schechter BF; Allard S
    Int J Clin Pharmacol Ther; 1996 Apr; 34(4):178-83. PubMed ID: 8861737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zolpidem for insomnia.
    Greenblatt DJ; Roth T
    Expert Opin Pharmacother; 2012 Apr; 13(6):879-93. PubMed ID: 22424586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications.
    Salvà P; Costa J
    Clin Pharmacokinet; 1995 Sep; 29(3):142-53. PubMed ID: 8521677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose response effects of zolpidem in normal geriatric subjects.
    Scharf MB; Mayleben DW; Kaffeman M; Krall R; Ochs R
    J Clin Psychiatry; 1991 Feb; 52(2):77-83. PubMed ID: 1993640
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EEG profile of intravenous zolpidem in healthy volunteers.
    Patat A; Trocherie S; Thebault JJ; Rosenzweig P; Dubruc C; Bianchetti G; Court LA; Morselli PL
    Psychopharmacology (Berl); 1994 Feb; 114(1):138-46. PubMed ID: 7846196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Zolpidem's use for insomnia.
    Monti JM; Spence DW; Buttoo K; Pandi-Perumal SR
    Asian J Psychiatr; 2017 Feb; 25():79-90. PubMed ID: 28262178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel zolpidem formulations.
    Owen RT
    Drugs Today (Barc); 2009 May; 45(5):395-400. PubMed ID: 19584967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Contribution of zolpidem in the management of sleep disorders].
    Lavoisy J; Zivkovic B; Benavides J; Perrault GH; Robert P
    Encephale; 1992; 18(4):379-92. PubMed ID: 1363657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration.
    Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Moline ML; Harris SC; Kapil RP
    J Clin Pharmacol; 2014 Mar; 54(3):282-90. PubMed ID: 24203450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Zolpidem: an update of its pharmacology, therapeutic efficacy and tolerability in the treatment of insomnia.
    Holm KJ; Goa KL
    Drugs; 2000 Apr; 59(4):865-89. PubMed ID: 10804040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rifampin reduces plasma concentrations and effects of zolpidem.
    Villikka K; Kivistö KT; Luurila H; Neuvonen PJ
    Clin Pharmacol Ther; 1997 Dec; 62(6):629-34. PubMed ID: 9433391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative tolerability, pharmacodynamics, and pharmacokinetics of a metabolite of a quinolizinone hypnotic and zolpidem in healthy subjects.
    Dingemanse J; Bury M; Hussain Y; van Giersbergen P
    Drug Metab Dispos; 2000 Dec; 28(12):1411-6. PubMed ID: 11095577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of daytime administration of zolpidem versus triazolam on memory.
    Wesensten NJ; Balkin TJ; Belenky GL
    Eur J Clin Pharmacol; 1995; 48(2):115-22. PubMed ID: 7589024
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter, placebo-controlled study evaluating zolpidem in the treatment of chronic insomnia.
    Scharf MB; Roth T; Vogel GW; Walsh JK
    J Clin Psychiatry; 1994 May; 55(5):192-9. PubMed ID: 8071269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of zolpidem after oral administration of a single dose in dogs.
    Giorgi M; Portela DA; Breghi G; Briganti A
    Am J Vet Res; 2012 Oct; 73(10):1650-6. PubMed ID: 23013193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics, pharmacodynamics, and relative pharmacokinetic/pharmacodynamic profiles of zaleplon and zolpidem.
    Drover D; Lemmens H; Naidu S; Cevallos W; Darwish M; Stanski D
    Clin Ther; 2000 Dec; 22(12):1443-61. PubMed ID: 11192136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.
    Olubodun JO; Ochs HR; von Moltke LL; Roubenoff R; Hesse LM; Harmatz JS; Shader RI; Greenblatt DJ
    Br J Clin Pharmacol; 2003 Sep; 56(3):297-304. PubMed ID: 12919178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kinetic and dynamic interaction study of zolpidem with ketoconazole, itraconazole, and fluconazole.
    Greenblatt DJ; von Moltke LL; Harmatz JS; Mertzanis P; Graf JA; Durol AL; Counihan M; Roth-Schechter B; Shader RI
    Clin Pharmacol Ther; 1998 Dec; 64(6):661-71. PubMed ID: 9871431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties.
    Blumer JL; Reed MD; Steinberg F; O'Riordan MA; Rosen CL; Springer MA; Christensen M; Glaze D;
    Clin Pharmacol Ther; 2008 Apr; 83(4):551-8. PubMed ID: 17957186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.